Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Radiotherapy and Erlotinib in Advanced Lung Cancer
NCT02714530Phase 2Terminated
- Sponsor
- Oslo University Hospital
- Start
- Apr 2014
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Oslo University Hospital. Started Apr 2014; status: terminated.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02714530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714530.